What is TRXA's health score?

T-REX Acquisition Corp. (TRXA) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TRXA's estimated fair value?

Based on our 5-year discounted cash flow model, T-REX Acquisition Corp.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is TRXA undervalued or overvalued?

Our model currently rates TRXA as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TRXA... Refresh in a moment for the full analysis.

T-REX Acquisition Corp. (TRXA)

Financials Inconclusive inconclusive weak

$0.51

Updated: 2026-06-04

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

85 Strong

Relative Value

40 Weak

Capital Allocation

20 Stressed

Risk

35 Weak

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.